Synergistic Effect between Cisplatin and Sunitinib Malate on Human Urinary Bladder-Cancer Cell Lines

作者: Regina Arantes-Rodrigues , Rosário Pinto-Leite , Lio Fidalgo-Gonçalves , Carlos Palmeira , Lúcio Santos

DOI: 10.1155/2013/791406

关键词:

摘要: The aim of this paper is to analyse sunitinib malate in vitro ability enhance cisplatin cytotoxicity T24, 5637, and HT1376 human urinary bladder-cancer cell lines. Cells were treated with (3, 6, 13, 18 μM) (1, 2, 4, 20 μM), either isolation or combined, over the course 72 hours. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay, acridine orange, monodansylcadaverine staining flow cytometry performed. combination index (CI) was calculated based on Chou Talalay method. In isolation, statistically (P < 0.05) decrease viability all lines a dose-dependent manner, presence autophagic vacuoles. A cycle arrest early S-phase G0/G1-phase also found after exposure malate, respectively. Treatment cells showed synergistic effect (CI 1). Autophagy apoptosis studies greater incidence when combined treatment put into use. This hints at possibility new therapeutic approach. If confirmed vivo, conjugation may provide means perspectives muscle-invasive bladder cancer treatment.

参考文章(42)
Rosário Pinto-Leite, Regina Arantes-Rodrigues, Paula A Oliveira, Aura Colaço, In vitro and in vivo experimental models as tools to investigate the efficacy of antineoplastic drugs on urinary bladder cancer. Anticancer Research. ,vol. 33, pp. 1273- 1296 ,(2013)
Szu-Yuan Ping, Chia-Lun Wu, Dah-Shyong Yu, Sunitinib can enhance BCG mediated cytotoxicity to transitional cell carcinoma through apoptosis pathway Urologic Oncology: Seminars and Original Investigations. ,vol. 30, pp. 652- 659 ,(2012) , 10.1016/J.UROLONC.2010.07.001
I. Nicoletti, G. Migliorati, M.C. Pagliacci, F. Grignani, C. Riccardi, A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry Journal of Immunological Methods. ,vol. 139, pp. 271- 279 ,(1991) , 10.1016/0022-1759(91)90198-O
Eric J. Askeland, Mark R. Newton, Michael A. O’Donnell, Yi Luo, Bladder Cancer Immunotherapy: BCG and Beyond Advances in Urology. ,vol. 2012, pp. 181987- 181987 ,(2012) , 10.1155/2012/181987
Yi Zhang, Yan Cheng, Xingcong Ren, Li Zhang, Kai Lee Yap, Hao Wu, Rajesh Patel, David Liu, Zheng-Hong Qin, Ie-Ming Shih, Jin-Ming Yang, NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response Oncogene. ,vol. 31, pp. 1055- 1064 ,(2012) , 10.1038/ONC.2011.290
Thomas Powles, Jacky Perry, Jonathan Shamash, Wai Liu, Tim Oliver, Simon Joel, A comparison of the platinum analogues in bladder cancer cell lines. Urologia Internationalis. ,vol. 79, pp. 67- 72 ,(2007) , 10.1159/000102917
Axel Niemann, Akira Takatsuki, Hans-Peter Elsässer, The lysosomotropic agent monodansylcadaverine also acts as a solvent polarity probe. Journal of Histochemistry and Cytochemistry. ,vol. 48, pp. 251- 258 ,(2000) , 10.1177/002215540004800210
Hans H. G. Verbeek, Maria M. Alves, Jan-Willem B. de Groot, Jan Osinga, John T. M. Plukker, Thera P. Links, Robert M. W. Hofstra, The Effects of Four Different Tyrosine Kinase Inhibitors on Medullary and Papillary Thyroid Cancer Cells The Journal of Clinical Endocrinology and Metabolism. ,vol. 96, ,(2011) , 10.1210/JC.2010-2381
Rosário Pinto-Leite, Regina Arantes-Rodrigues, Carlos Palmeira, Bruno Colaço, Carlos Lopes, Aura Colaço, Céu Costa, Vítor Moreira da Silva, Paula Oliveira, Lúcio Santos, Everolimus combined with cisplatin has a potential role in treatment of urothelial bladder cancer Biomedicine & Pharmacotherapy. ,vol. 67, pp. 116- 121 ,(2013) , 10.1016/J.BIOPHA.2012.11.007
Feng Pan, Jing Tian, Xuchao Zhang, Ying Zhang, Yueyin Pan, Synergistic interaction between sunitinib and docetaxel is sequence dependent in human non–small lung cancer with EGFR TKIs-resistant mutation Journal of Cancer Research and Clinical Oncology. ,vol. 137, pp. 1397- 1408 ,(2011) , 10.1007/S00432-011-1009-X